Skip to main content

Table 1 Clinical and biochemical data of the study population

From: Apolipoprotein E gene polymorphism and the risk of cardiovascular disease and type 2 diabetes

Variables CVD- CVD+
T2DM- (n = 211) T2DM+ (n = 247) T2DM- (n = 232) T2DM+ (n = 234)
Age (Years) 60.65 ± 11.72 61.52 ± 11.61 63.05 ± 11.79## 64.61 ± 10.95&&
Sex (male/female) 109/102 127/119 126/106## 119/115 &&
SBP (mmHg) 124.49 ± 14.90 141.26 ± 24.43*** 129.43 ± 22.18## 140.30 ± 24.86&&&
DBP (mmHg) 77.03 ± 10.75 81.60 ± 15.34*** 79.32 ± 16.67 83.12 ± 14.73&&&
Hypertension (%) 96(38.8%) 59(25.4%) 145(61.9%)
Dyslipidemia (%) 96(38.8%) 41(17.6%) 54(23.0%)
Smokers (%) 41(19.4%) 46(18.6%) 74(31.8%)## 56(23.9%)
Glucose (mg/dL) 5.29 ± 1.27 14.29 ± 6.16*** 5.26 ± 1.16 8.86 ± 3.34&&&
Triglyceride (mg/dL) 1.59 ± 0.93 2.75 ± 3.64*** 1.50 ± 0.96 2.28 ± 1.75&&&
TC (mg/dL) 4.21 ± 1.29 5.67 ± 1.84*** 5.02 ± 1.21### 5.00 ± 1.36&&&
LDL-C (mg/dL) 2.31 ± 0.88 3.12 ± 1.06*** 2.81 ± 0.91### 2.76 ± 0.99&&&
HDL-C (mg/dL) 1.33 ± 0.43 1.27 ± 0.37 1.32 ± 0.34 1.17 ± 0.32&&&
ApoA1 (mg/dL) 1.08 ± 0.36 1.17 ± 0.33** 1.13 ± 0.28 1.09 ± 0.31
ApoB (mg/dL) 0.72 ± 0.27 0.96 ± 0.33*** 0.84 ± 0.26### 0.88 ± 0.31&&
  1. Data are presented as mean ± SD, or numbers (N) and percentage
  2. *p-value: comparison between CVD-T2DM+ and control
  3. # p-value: comparison between CVD + T2DM - and control
  4. &p-value: comparison between CVD + T2DM + and control
  5. SBP systolic blood pressure, DBP diastolic blood pressure, TC total cholesterol, LDL-C low density lipoprotein cholesterol, TG triglyceride, HDL-C high density lipoprotein cholesterol